Journal rankings · indicator year 2020
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Field ranking · 2020
Pharmacology, Toxicology and Pharmaceutics journal rankings 2020
70 ranked journals · Field in Life Sciences
Pharmacology, Toxicology and Pharmaceutics has 70 ranked journals in 2020. The median OJR rose 0.15 on 2019 to 0.77, below the world average of 1.00; Q1 starts at OJR 1.24. The top three are Expert Opinion on Drug Delivery, Drug Delivery, and Journal of Pharmaceutical Investigation.
Ranks and citation indicators: 2020. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2017–2019, the window the 2020 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields in Pharmacology, Toxicology and Pharmaceutics (4)
Up to Life Sciences70 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2019. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2017–2019, the window the 2020 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2017–2019 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2011 to 2020. | Compare |
|---|---|---|---|---|---|---|---|
1Expert Opinion on Drug DeliveryTaylor & Francis · United Kingdom | 2.04Q1 | 7.31 2.93 up from 2019 | 222 | 34% | — | ||
2Drug DeliveryOATaylor & Francis · United Kingdom | 1.98Q1 | 7.69 2.09 up from 2019 | 509 | 100% | $2,864 | ||
3Journal of Pharmaceutical InvestigationSpringer Science+Business Media · South Korea | 1.90Q1 | 7.13 2.50 up from 2019 | 161 | 25% | $3,890 | ||
4European Journal of Pharmaceutics and BiopharmaceuticsElsevier BV · Netherlands | 1.74Q1 | 6.27 1.24 up from 2019 | 816 | 35% | $4,210 | ||
5International Journal of PharmaceuticsElsevier BV · Netherlands | 1.70Q1 | 6.10 0.72 up from 2019 | 2,646 | 28% | $4,650 | ||
6Drug SafetyAdis, Springer Healthcare · New Zealand | 1.68Q1 | 5.56 1.71 up from 2019 | 359 | 64% | $4,990 | ||
7Clinical and Translational ScienceOAWiley · United Kingdom | 1.59Q1 | 3.94 0.44 up from 2019 | 267 | 100% | $3,630 | ||
8Expert Opinion on Drug Metabolism & ToxicologyTaylor & Francis · United Kingdom | 1.57Q1 | 4.88 1.23 up from 2019 | 267 | 34% | — | ||
9Expert Opinion on Drug SafetyTaylor & Francis · United Kingdom | 1.51Q1 | 4.78 0.71 up from 2019 | 355 | 25% | — | ||
10Forensic ToxicologySpringer Science+Business Media · Japan | 1.50Q1 | 3.43 0.48 up from 2019 | 160 | 38% | $2,990 | ||
11International Journal of Pharmaceutics XOAElsevier BV · Netherlands | 1.46Q1 | 4.54 3.87 up from 2019 | 37 | 100% | $2,590 | ||
12Drug Delivery and Translational ResearchSpringer Science+Business Media · United States | 1.37Q1 | 5.06 1.89 up from 2019 | 339 | 32% | $4,690 | ||
13Pharmaceutical ResearchSpringer Science+Business Media · United States | 1.35Q1 | 4.69 1.00 up from 2019 | 622 | 40% | $4,690 | ||
14Journal of Analytical ToxicologyOxford University Press · United Kingdom | 1.35Q1 | 3.71 0.13 up from 2019 | 321 | 27% | $4,823 | ||
15European Journal of Pharmaceutical SciencesOAElsevier BV · Netherlands | 1.35Q1 | 4.51 0.64 up from 2019 | 1,298 | 24% | $3,070 | ||
16Scientia PharmaceuticaOAÖsterreichische Apotheker-Verlagsgesellschaft m. b. H. · Switzerland | 1.28Q1 | 4.40 1.95 up from 2019 | 123 | 100% | $1,207 | ||
17Future Journal of Pharmaceutical SciencesOASpringer Science+Business Media · Egypt | 1.28Q1 | 4.52 2.07 up from 2019 | 74 | 100% | $0 listed | ||
18Forensic ChemistryElsevier BV · Netherlands | 1.24Q1 | 3.10 0.69 up from 2019 | 184 | 34% | $4,530 | ||
19Current Drug MetabolismBentham Science Publishers · Netherlands | 1.24Q2 | 4.11 0.91 up from 2019 | 275 | 22% | — | ||
20Drug Metabolism and DispositionAmerican Society for Pharmacology and Experimental Therapeutics · United States | 1.18Q2 | 4.18 0.68 up from 2019 | 497 | 86% | $3,500 | ||
21Journal of Drug Delivery Science and TechnologyElsevier BV · France | 1.18Q2 | 4.42 1.11 up from 2019 | 1,201 | 10% | $3,810 | ||
22Journal of MicroencapsulationTaylor & Francis · United Kingdom | 1.12Q2 | 3.60 0.82 up from 2019 | 199 | 5% | — | ||
23The Pharmacogenomics JournalSpringer Nature · United Kingdom | 1.10Q2 | 3.25 0.03 down from 2019 | 189 | 43% | $4,890 | ||
24Drug Development and Industrial PharmacyTaylor & Francis · United States | 1.09Q2 | 3.59 0.81 up from 2019 | 544 | 25% | — | ||
25AAPS PharmSciTechSpringer Science+Business Media · United States | 1.08Q2 | 3.86 0.99 up from 2019 | 841 | 21% | $4,190 | ||
26Drug Metabolism and PharmacokineticsElsevier BV · Japan | 1.02Q2 | 2.71 0.12 down from 2019 | 136 | 5% | $3,580 | ||
27Drug Testing and AnalysisWiley · United States | 1.01Q2 | 3.19 0.42 up from 2019 | 517 | 36% | $4,440 | ||
28Pharmacogenetics and GenomicsLippincott Williams & Wilkins · United Kingdom | 1.00Q2 | 1.91 1.07 down from 2019 | 131 | 48% | — | ||
29Critical Reviews in Therapeutic Drug Carrier SystemsBegell House · United States | 0.96Q2 | 3.36 1.26 up from 2019 | 46 | 4% | — | ||
30Therapeutic DeliveryFuture Science Ltd · United Kingdom | 0.92Q2 | 3.10 0.42 up from 2019 | 240 | 24% | — | ||
31Pharmaceutical NanotechnologyBentham Science Publishers · Netherlands | 0.88Q2 | 3.59 1.51 up from 2019 | 97 | 30% | — | ||
32Pharmaceutical Development and TechnologyTaylor & Francis · United States | 0.88Q2 | 3.05 0.99 up from 2019 | 285 | 12% | — | ||
33European Journal of Drug Metabolism and PharmacokineticsAdis, Springer Healthcare · France | 0.83Q2 | 2.06 0.14 up from 2019 | 199 | 40% | $2,690 | ||
34Current Drug DeliveryBentham Science Publishers · Netherlands | 0.79Q2 | 3.04 1.36 up from 2019 | 253 | 15% | — | ||
35PharmacogenomicsFuture Medicine · United Kingdom | 0.79Q2 | 2.14 0.29 down from 2019 | 394 | 29% | — | ||
36Drug Metabolism and Personalized TherapyDe Gruyter · Germany | 0.76Q3 | 2.31 0.81 up from 2019 | 83 | 8% | $2,712 | ||
37Journal of Pharmaceutical Health Care and SciencesOABioMed Central · United Kingdom | 0.68Q3 | 1.82 0.44 up from 2019 | 86 | 100% | $2,490 | ||
38Journal of Pharmaceutical InnovationSpringer Science+Business Media · United Kingdom | 0.66Q3 | 2.11 0.68 up from 2019 | 150 | 21% | $3,990 | ||
39XenobioticaTaylor & Francis · United Kingdom | 0.60Q3 | 1.87 0.35 up from 2019 | 396 | 36% | — | ||
40Biopharmaceutics & Drug DispositionWiley · United Kingdom | 0.59Q3 | 1.89 0.38 up from 2019 | 119 | 23% | $3,800 | ||
41Brazilian Journal of Pharmaceutical SciencesOAUniversity of São Paulo · Brazil | 0.55Q3 | 1.66 0.63 up from 2019 | 406 | 100% | — | ||
42Journal of Fluorine ChemistryElsevier BV · Netherlands | 0.53Q3 | 1.89no change | 589 | 15% | $3,660 | ||
43Recent Patents on Drug Delivery & FormulationBentham Science Publishers · Netherlands | 0.52Q3 | 1.83 0.73 up from 2019 | 68 | 58% | — | ||
44Drug Metabolism LettersBentham Science Publishers · Netherlands | 0.47Q3 | 1.42 0.55 up from 2019 | 54 | 18% | — | ||
45Assay and Drug Development TechnologiesMary Ann Liebert, Inc. · United States | 0.46Q3 | 1.51 0.32 up from 2019 | 135 | 14% | — | ||
46ADMET & DMPKOAInternational Association of Physical Chemists (IAPC) · Croatia | 0.41Q3 | 1.64 0.40 up from 2019 | 59 | 100% | — | ||
47Indian Journal of Pharmaceutical Education and ResearchAssociation of Pharmaceutical Teachers of India · India | 0.39Q3 | 0.94 0.16 up from 2019 | 524 | 96% | — | ||
48Recent Patents on NanotechnologyBentham Science Publishers · Netherlands | 0.38Q3 | 1.39 0.27 up from 2019 | 86 | 29% | — | ||
49Current NanomedicineNetherlands | 0.32Q3 | 1.56 1.01 up from 2019 | 79 | 29% | — | ||
50International Journal of Pharmacy and Pharmaceutical SciencesOAInnovare Academic Sciences · India | 0.27Q3 | 0.77 0.23 down from 2019 | 939 | 100% | — |
Subfields of Pharmacology, Toxicology and Pharmaceutics, compared.
Journals
Citations made in 2020. Corpus-wide, 86.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
29 additional Pharmacology, Toxicology and Pharmaceutics journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2017–2019, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2020. Publication window: 2017–2019. How these summaries are calculated
- Ranked journals
- 70
- Window papers (baseline)
- 51,606 -8.4% from indicator year 2017
- Median OJR
- 0.77 +7.9% from indicator year 2017
- Rising journals (2025)
- 4Comparison-group list (4)
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2017–2019 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 23 | 27 | 30 | 32 | 32 | 34 | 37 | 38 | 40 | 43 | 44 | 49 | 54 | 61 | 69 | 71 | 74 | 71 | 73 | 75 | 70 | 72 | 75 | 73 | 72 | 68 | |
| Window papers (baseline) | 20,428 | 21,714 | 23,158 | 25,397 | 26,889 | 29,157 | 31,606 | 34,777 | 38,146 | 41,640 | 45,814 | 49,553 | 53,613 | 56,245 | 59,173 | 59,681 | 59,061 | 56,321 | 53,536 | 51,719 | 51,606 | 54,267 | 56,608 | 57,539 | 56,944 | 58,541 | |
| Median OJR | 0.620 | 0.717 | 0.722 | 0.88 | 0.86 | 0.83 | 0.91 | 1.11 | 0.9471 | 0.97 | 0.949 | 1.03 | 0.9469 | 0.80 | 0.70 | 0.720 | 0.61 | 0.7184 | 0.74 | 0.628 | 0.77 | 0.621 | 0.67 | 0.630 | 0.625 | 0.7176 |
| Measure | Category statistic | Eligible population |
|---|---|---|
| Journal self-citation share | Median: 2.7% | 62 journals |
| Retracted papers per 1,000 | Pooled rate: 1.221 per 1,000 | 51 journals |
| Output growth | Median: -1.6% | 60 journals |
| Open access share | Median: 44.5% | 68 journals |
| Listed APC (USD) | Median including $0 listed prices: $3,605 | 32 ranked journals with a known listed price, including $0 listed prices |
| International collaboration share | Median: 22.2% | 67 journals |
| Review share | Median: 0.4% | 68 journals |
| Articles-only OJR | Median: 0.74 | 68 journals |
| Uncited share | Median: 25.2% | 68 journals |
| Citation concentration | Median: 43.7% | 68 journals |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.